CSF interleukin 6 is a useful marker to distinguish pseudotumoral CNS inflammatory diseases from primary CNS lymphoma.
Aurelian UngureanuMagali Le Garff-TavernierMyrto CostopoulosTimothée ParratteAbdelmalek BrinetHélène DurandClaude GaultierRemy HurstelIsabelle AlamomeFrançois SellalGuido AhlePublished in: Journal of neurology (2021)
Our study suggests that CSF IL-6 levels could represent, in addition to CSF IL-10, a useful biomarker in the differential diagnosis of CNSID and suspected PCNSL.